Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study.

Sandfort V, Bluemke DA, Vargas J, Brinker JA, Gerstenblith G, Kickler T, Zheng G, Li J, Chen S, Lai H, Fishman EK, Lai S.

J Addict Med. 2017 Mar/Apr;11(2):126-137. doi: 10.1097/ADM.0000000000000282.

PMID:
28060223
2.

A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence.

Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA.

Drug Alcohol Depend. 2016 Mar 1;160:135-42. doi: 10.1016/j.drugalcdep.2015.12.036. Epub 2016 Jan 13.

3.

Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Kiluk BD, Carroll KM, Duhig A, Falk DE, Kampman K, Lai S, Litten RZ, McCann DJ, Montoya ID, Preston KL, Skolnick P, Weisner C, Woody G, Chandler R, Detke MJ, Dunn K, Dworkin RH, Fertig J, Gewandter J, Moeller FG, Ramey T, Ryan M, Silverman K, Strain EC.

Drug Alcohol Depend. 2016 Jan 1;158:1-7. doi: 10.1016/j.drugalcdep.2015.11.004. Epub 2015 Nov 21. Review.

4.

Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study.

Lai H, Stitzer M, Treisman G, Moore R, Brinker J, Gerstenblith G, Kickler TS, Li J, Chen S, Fishman E, Lai S.

J Addict Med. 2015 Jul-Aug;9(4):331-9. doi: 10.1097/ADM.0000000000000140.

5.

Prompted to treatment by the criminal justice system: Relationships with treatment retention and outcome among cocaine users.

Kiluk BD, Serafini K, Malin-Mayor B, Babuscio TA, Nich C, Carroll KM.

Am J Addict. 2015 Apr;24(3):225-32. doi: 10.1111/ajad.12208. Epub 2015 Mar 24.

6.

Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users.

Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Silverman K.

J Appl Behav Anal. 2014 Winter;47(4):681-93. doi: 10.1002/jaba.158. Epub 2014 Oct 8.

7.

Coronary artery manifestations of fibromuscular dysplasia.

Michelis KC, Olin JW, Kadian-Dodov D, d'Escamard V, Kovacic JC.

J Am Coll Cardiol. 2014 Sep 9;64(10):1033-46. doi: 10.1016/j.jacc.2014.07.014. Review.

8.

Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Carroll KM, Kiluk BD, Nich C, DeVito EE, Decker S, LaPaglia D, Duffey D, Babuscio TA, Ball SA.

Drug Alcohol Depend. 2014 Apr 1;137:3-19. doi: 10.1016/j.drugalcdep.2014.01.012. Epub 2014 Jan 31. Review.

9.

Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.

Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ.

Exp Clin Psychopharmacol. 2014 Jun;22(3):248-56. doi: 10.1037/a0035712. Epub 2014 Feb 17.

10.

Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment.

McCauley JL, Killeen T, Gros DF, Brady KT, Back SE.

Clin Psychol (New York). 2012 Sep 1;19(3). doi: 10.1111/cpsp.12006.

11.

Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.

Gurvich EM, Kenna GA, Leggio L.

Alcohol Alcohol. 2013 Nov-Dec;48(6):712-9. doi: 10.1093/alcalc/agt134. Epub 2013 Aug 17. Review.

12.

A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.

LaRowe SD, Kalivas PW, Nicholas JS, Randall PK, Mardikian PN, Malcolm RJ.

Am J Addict. 2013 Sep-Oct;22(5):443-52. doi: 10.1111/j.1521-0391.2013.12034.x. Epub 2013 May 15.

13.

Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial.

Carroll KM, Nich C, Shi JM, Eagan D, Ball SA.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):224-31. doi: 10.1016/j.drugalcdep.2012.05.019. Epub 2012 Jun 12.

14.

Maintenance of reinforcement to address the chronic nature of drug addiction.

Silverman K, DeFulio A, Sigurdsson SO.

Prev Med. 2012 Nov;55 Suppl:S46-53. doi: 10.1016/j.ypmed.2012.03.013. Epub 2012 Jun 5.

15.
16.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, O'Brien CP.

J Subst Abuse Treat. 2012 Oct;43(3):303-12. doi: 10.1016/j.jsat.2011.12.014. Epub 2012 Feb 27.

17.

The Obsessive Compulsive Cocaine Scale: assessment of factor structure, reliability, and validity.

Jardin BF, Larowe SD, Hall BJ, Malcolm RJ.

Addict Behav. 2011 Dec;36(12):1223-7. doi: 10.1016/j.addbeh.2011.07.028. Epub 2011 Jul 29.

18.

Power of automated algorithms for combining time-line follow-back and urine drug screening test results in stimulant-abuse clinical trials.

Oden NL, VanVeldhuisen PC, Wakim PG, Trivedi MH, Somoza E, Lewis D.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):350-7. doi: 10.3109/00952990.2011.601777.

19.

Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037).

Trivedi MH, Greer TL, Potter JS, Grannemann BD, Nunes EV, Rethorst C, Warden D, Ring KM, Somoza E.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):339-49. doi: 10.3109/00952990.2011.598589.

20.

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.

Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, Wells EA.

Addiction. 2012 Apr;107(4):694-708. doi: 10.1111/j.1360-0443.2011.03473.x. Epub 2011 Jul 22.

Supplemental Content

Support Center